Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid reduces blood loss of laminectomy and fusion for multilevel cervical myelopathy
ChiCTR-IPQ-16008539Phase 4Recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cervical myelopathy comparing Placebo (0.9% NaCl) with Tranexamic acid (2 arms). Primary endpoint: blood loss. Started Jun 2016; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
cervical myelopathy
Beyond the preview
Go deeper on ChiCTR-IPQ-16008539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPQ-16008539.